Company Search:
Advanced Search
Sponsored Links
Sanofi Aventis Pakistan Ltd Company Snapshot
Sanofi Aventis Pakistan Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi Aventis Pakistan Ltd with three other companies in this sector in Pakistan: Searle Co Ltd (2015 sales of 9.05 billion Pakistan Rupees [US$86.41 million] ), Ferozsons Laboratories Limited (5.71 billion Pakistan Rupees [US$54.49 million] ), and Highnoon Laboratories Limited (4.40 billion Pakistan Rupees [US$42.06 million] ).

Sales Analysis. During the year ended December of 2015, sales at Sanofi Aventis Pakistan Ltd were 10.79 billion Pakistan Rupees (US$103.01 million). This is an increase of 8.4% versus 2014, when the company's sales were 9.95 billion Pakistan Rupees. This was the fifth consecutive year of sales increases at Sanofi Aventis Pakistan Ltd (and since 2010, sales have increased a total of 77%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sanofi Aventis Pakistan Ltd
  Stock Performance Chart for Sanofi Aventis Pakistan Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 1,302.00
(Figures in Pakistan Rupees)
1 Week -2.0%   13 Weeks 31.2%  
4 Weeks 132.5%   52 Weeks 97.3%  
Sanofi Aventis Pakistan Ltd Key Data:
  Ticker: SAPL Country: Pakistan
  Exchanges: KAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 10,785,879,000
(Year Ending Jan 2016).
Employees: 1,014
  Currency: Pakistan Rupees Market Cap: 12,557,477,520
  Fiscal Yr Ends: December Shares Outstanding: 9,644,760
  Share Type: Ordinary Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.